The correct answer is; Insurance plans that are sold on the Marketplace, "most" small group and individual plans, and all state Medicare plans must provide some mental health services. The act states that there must be more than 50 workers.
Further Explanation:
The Mental Health Parity Act began in 1996 and the Mental Health Parity and Addiction Equity Act began in 2008. The MHPA of 1996 was started to help people with mental health issues get the needed help. This prevents insurance companies and any HMOs to place place limits, either annually or lifetime, that are on a plan with surgical and medical benefits on the plan.
Under this law, there is a a limit on how many days a patient can stay in an inpatient setting, outpatient appointments, raising the deductible on the insurance, and also the prescription psych medications.
Learn more about mental illness at brainly.com/question/933852
#LearnwithBrainly
defence cell in blood are called white blood cells
Answer:
1. Source of concentrated energy (diet and main storage form)
2.Provides essential fatty acids
3. Adds flavor and texture to foods
4. Carrier of fat soluble vitamins ADEK
5. Body insulation and padding around organs
6. Cell signaling pathways
Explanation:
In the given scenario, icd-10-cm code reported is H02.423.
What is icd-10-cm code?
The ICD-10-CM is a morbidity classification developed by the United States that is used to classify diagnoses and reasons for visits in all health care settings.
Upper eyelid drooping is caused by a muscle disorder (myogenic). Look for Ptosis/eyelid in the ICD-10-CM Alphabetical Index, which states to see Blepharoptosis.
Look for Blepharoptosis and you'll be directed to H02.423, where the sixth character indicates laterality.
The sixth character of three stands for bilateral. There is only one code for both eyelids, not two separate codes.
This, this should be the icd-10-cm code.
For more details regarding icd-10-cm code, visit:
brainly.com/question/14819864
#SPJ4
Vaccines are the most efficacious means of minimizing the impact of infectious diseases on the human population. The challenges and importance of making vaccines that will meet FDA approval have never been greater. Genomics has the potential to improve the process of vaccine development substantially. Genome sequencing can help to identify genetic patterns related to the virulence of a disease, as well as genetic factors that contribute to immunity or successful vaccine response. All this information could lead to vaccines with better and more specific targets that elicit more successful protective immune responses. Comparing the genome sequences of viruses that cause infection with those that do not may provide additional insights. In turn, genome manipulation can facilitate derivation of attenuated strains or other vehicles for delivery of the desired antigens to stimulate immune response. On the other end of the spectrum, analysis of host diversity can reveal effective immune responses and possibly the genetic basis for inappropriate response. The recent progress in definition of the innate immune system, necessary for acquired response, should facilitate the definition of this host diversity.
